The company said it will seek an expanded indication for the left atrial appendage closure device after it met all safety and ...
Physicians wrestled with endpoint composition, low event rates, a possible difference in ischemic strokes, and more.
Boston presented the pair of trial readouts at the 2026 American College of Cardiology (ACC) conference in New Orleans.
In one of the largest studies of its kind, a trial of Boston Scientific’s small, permanent cardiac implant showed that it could potentially serve as an alternative to long-term blood thin | Boston ...
A new Watchman device at McLaren Port Huron offers eligible AFib patients an alternative to long‑term blood thinners to help ...
NEW ALBANY — Baptist Health Floyd recently completed its 500th Watchman procedure. The Watchman device is an alternative to ...
CHAMPION-AF shows Boston Scientific's Watchman FLX as a safe, effective first-line option for stroke risk reduction in ...
Boston Scientific (NYSE:BSX) announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system.
LOS ANGELES (KABC) -- A Los Angeles cardiac specialist said a newly approved device may be life changing for many patients with irregular heart rhythms. The newly FDA-approved Watchman device is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results